Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 17;30(2):265-269.
doi: 10.1080/09273948.2020.1825750. Epub 2020 Oct 6.

Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome

Affiliations

Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome

Maria F Golzarri et al. Ocul Immunol Inflamm. .

Abstract

Purpose: To identify the risk factors for the development of subretinal fibrosis (SRF) among patients with Vogt-Koyanagi-Harada (VKH) syndrome.

Methods: In this case-control study, electronic clinical records from patients diagnosed with VKH syndrome who attended the Inflammatory Eye Disease Clinic at a tertiary care ophthalmology reference center were assessed to identify risk factors from demographic, clinical, and epidemiological variables. Cases were defined as SRF and VKH, whereas the controls were VKH patients without SRF.

Results: A total of 150 electronic charts were reviewed, 92 patients with a follow-up longer than 12 months were included; 39 cases and 53 controls. A multivariate analysis found bullous serous retinal detachment as a significant risk factor for SRF (adjusted OR 8.93, 95% CI 1.94-41.1).

Conclusion: Patients with VKH syndrome who develop a bullous retinal detachment have an 8 times higher risk of developing SRF in the long term.

Keywords: Vogt Koyanagi Harada; bullous retinal detachment; retinal complications; subretinal fibrosis; vkh.

PubMed Disclaimer

Comment in

  • Subretinal Fibrosis in Uveitis.
    Cunningham ET Jr, Smit DP, Zierhut M. Cunningham ET Jr, et al. Ocul Immunol Inflamm. 2022 Feb 17;30(2):263-264. doi: 10.1080/09273948.2022.2043079. Ocul Immunol Inflamm. 2022. PMID: 35442874 No abstract available.

LinkOut - more resources